List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 515 studies with search of: Attention Deficit Disorder
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Treatment of Patients With Alcoholism and Attention Deficit Disorder
Conditions: Alcoholism;   Attention Deficit Disorder
Intervention: Drug: Methylphenidate
2 Completed Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: NRP104
3 Completed An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate hydrochloride
4 Completed
Has Results 		An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: Vyvanse (lisdexamfetamine dimesylate), NRP104
5 Not yet recruiting Pilot Study of Duloxetine in Adult ADHD
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: duloxetine;   Drug: placebo
6 Completed A Safety and Effectiveness Study of Methylphenidate HCl Extended-Release Tablets in Adults With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate hydrochloride extended-release tablets
7 Recruiting Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Behavioral: Breathing Meditation
8 Recruiting Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits
Conditions: Traumatic Brain Injury;   Attention Deficit Disorder
Interventions: Drug: Vyvanse;   Procedure: fMRI
9 Recruiting International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit/Hyperactivity Disorder
Intervention: Drug: short-acting methylphenidate
10 Recruiting A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Interventions: Drug: JNJ-31001074 1 mg/d;   Drug: JNJ-31001074 10 mg/d;   Drug: Atomoxetine 80 mg/d;   Drug: OROS methylphenidate HCl 54 mg/d;   Drug: JNJ-31001074 3 mg/d;   Drug: Placebo
11 Recruiting A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
12 Recruiting A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
13 Completed Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
Conditions: Attention Deficit Disorder With Hyperactivity;   Substance-Related Disorders;   Dyssocial Behavior
Interventions: Behavioral: Psychosocial treatment;   Drug: Anti-ADHD medication;   Behavioral: Assessment-and-Referral
14 Completed Further Studies of Attention Deficit Disorder - Residual Type (RT)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: methylphenidate;   Drug: placebo
15 Completed A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: methylphenidate hydrochloride extended-release tablets
16 Completed Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
Condition: Attention Deficit Disorder
Intervention: Drug: Extended-release bupropion hydrochloride
17 Recruiting A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: LY2216684;   Drug: Methylphenidate;   Drug: Placebo (tablet);   Drug: Placebo (capsule)
18 Completed Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: clonidine;   Drug: methylphenidate;   Other: placebo
19 Completed CONCERTA® (OROS® Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate
20 Recruiting Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services